BMT101

DRUG2 trials

Sponsors

Hugel

Conditions

Hypertrophic Scar

Phase 1

Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers

CompletedNCT03133130

HugelHypertrophic Scar

Start: 2017-07-31End: 2018-02-14Updated: 2018-04-25

Phase 2

the Hypertrophic Scar Prevention of BMT101.

TerminatedNCT04012099

HugelHypertrophic Scar

Start: 2019-08-21End: 2023-05-10Updated: 2023-05-24